Premium
Commentary: tenofovir is superior to entecavir in HBeAg‐positive chronic hepatitis B patients
Author(s) -
Bradshaw D.,
Danta M.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12675
Subject(s) - entecavir , medicine , hbeag , seroconversion , gastroenterology , tenofovir , hepatitis b virus , chronic hepatitis , population , virology , hepatitis b , viral load , immunology , virus , hbsag , lamivudine , human immunodeficiency virus (hiv) , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom